Abstract
AbstractRepetitive transcranial magnetic stimulation (rTMS), when applied to left dorsolateral prefrontal cortex (LDLPFC), reduces negative symptoms of schizophrenia, but has no effect on positive symptoms. In a small number of cases, it appears to worsen the severity of positive symptoms. It has been hypothesized that high-frequency rTMS of the LDLPFC might increase the dopaminergic neurotransmission by driving the activity of the left striatum in the basal ganglia (LSTR)—increasing striatal dopaminergic activity. This hypothesis relies on the assumption that either the frontal–striatal connection or the intrinsic frontal and/or striatal connections covary with the severity of positive symptoms. The current work aimed to evaluate this assumption by studying the association between positive and negative symptoms severity and the effective connectivity within the frontal and striatal network using dynamic causal modeling of resting state fMRI in a sample of 19 first episode psychosis subjects. We found that the total score of positive symptoms of schizophrenia is strongly associated with the frontostriatal circuitry. Stronger intrinsic inhibitory tone of LDLPFC and LSTR, as well as decreased bidirectional excitatory influence between the LDLPFC and the LSTR is related to the severity of positive symptoms, especially delusions. We interpret that an increase in striatal dopaminergic tone that underlies positive symptoms is likely associated with increased prefrontal inhibitory tone, strengthening the frontostriatal ‘brake’. Furthermore, based on our model, we propose that lessening of positive symptoms could be achieved by means of continuous theta-burst or low-frequency (1 Hz) rTMS of the prefrontal area.
Funder
CIHR Foundation Grant
BrainsCAN
AMOSO Opportunities Fund
Canada Graduate Scholarship
Schulich School of Medicine Clinical Investigator Fellowship
Schulich School of Medicine and Dentistry Department of Psychiatry Seed Grant
Buck Family Fund
Parkwood Institute Studenship
Canada First Research Excellence Fund to BrainsCAN
Western University
Innovation fund for Academic Medical Organization of Southwest Ontario
The Chrysalis Foundation and The Arcangelo Rea Family Foundation
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,General Medicine
Reference56 articles.
1. Andreasen NC, Carpenter WTJ, Kane JM, Lasser RA, Marder SR, Weinberger DR (2005) Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 162:441–449
2. Association AP (2013) Diagnostic and statistical manual of mental disorders. American Psychiatric Publishing, Inc, Arlington, pp 991
3. Carlsson A, Waters N, Carlsson ML (1999) Neurotransmitter interactions in schizophrenia—therapeutic implications. Biol Psychiatry 46:1388–1395
4. Coyle JT (1996) The glutamatergic dysfunction hypothesis for schizophrenia. Harv Rev Psychiatr 3:241–253
5. Friston K, Zeidman P, Litvak V (2015) Empirical bayes for dcm: a group inversion scheme. Front Syst Neurosci 9:164
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献